Combinations of conventional disease-modifying antirheumatic drugs

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

During the last decade, numerous new treatments and treatment approaches have literally transformed current thinking about rheumatoid arthritis (RA) and more, importantly, about the way patients are treated. The nearly universal acceptance of the use of combinations of disease-modifying antirheumatic drugs (DMARDs) to more effectively treat a growing percentage of patients with RA has been a central theme. Importantly controlled studies have no shown many combinations to be well tolerated and significantly more effective than mono-DMARD therapy.

Original languageEnglish (US)
Pages (from-to)415-426
Number of pages12
JournalRheumatic Disease Clinics of North America
Volume27
Issue number2
DOIs
StatePublished - Jan 1 2001

ASJC Scopus subject areas

  • Rheumatology

Fingerprint Dive into the research topics of 'Combinations of conventional disease-modifying antirheumatic drugs'. Together they form a unique fingerprint.

  • Cite this